Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 4,808.90 | 2,589.70 | 2,838.10 | 2,284.80 |
Depreciation/ Depletion | 764.10 | 722.70 | 736.10 | 724.80 |
Non- Cash Items | -99.90 | 516.30 | -162.70 | 507.00 |
Changesin Working Capital | -2,239.20 | -1,139.90 | -1,333.30 | -331.50 |
Cashfrom Operating Activities | 3,233.90 | 2,688.80 | 2,078.20 | 3,185.10 |
Capital Expenditures | -906.60 | -1,030.90 | -1,202.60 | -854.00 |
Other Investing Cash Flow Items Total | -568.60 | 2,202.10 | 2,357.00 | 131.50 |
Cashfrom Investing Activities | -1,475.20 | 1,171.20 | 1,154.40 | -722.50 |
Financing Cash Flow Items | -72.90 | -126.20 | -111.10 | -323.30 |
Total Cash Dividends Paid | -621.00 | -267.10 | -372.20 | -1.50 |
Issuance( Retirement)of Stock Net | -725.00 | -863.20 | - | 986.60 |
Issuance( Retirement)of Debt Net | -391.50 | -3,143.90 | -385.00 | -3,210.70 |
Cashfrom Financing Activities | -1,810.40 | -4,400.40 | -868.30 | -2,548.90 |
Foreign Exchange Effects | -23.10 | 6.60 | 8.60 | -4.20 |
Net Changein Cash | -74.80 | -533.80 | 2,372.90 | -90.50 |
Cash Taxes Paid | 1,285.80 | 592.00 | 674.60 | 345.00 |
Zydus Lifesciences Dividend Zydus Lifesciences Bonus Zydus Lifesciences News Zydus Lifesciences AGM Zydus Lifesciences Rights Zydus Lifesciences Splits Zydus Lifesciences Board Meetings Zydus Lifesciences Key Metrics Zydus Lifesciences Shareholdings Zydus Lifesciences Profit Loss Zydus Lifesciences Balance Sheet Zydus Lifesciences Q1 Results Zydus Lifesciences Q2 Results Zydus Lifesciences Q3 Results Zydus Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks